The government of Odisha has approved the Biotechnology Policy 2024 to create a flourishing ecosystem for the biotech industry. This will further promote higher education, research & infrastructure development in the sector and strengthen the supportive ecosystem for innovation, incubation, investment, income & impact to build enterprises. Association of Biotechnology …
In an apparent setback to the genetically modified (gm) foods industry, Kenya has destroyed its first gm maize crop planted in open field trials. The move followed the detection that a technician had sprayed Furadan, a restricted pesticide, on the maize modified to resist attack by insects called stem borers. …
the Orissa government recently prepared a draft of its Biotechnology Policy 2005. A first glance at the policy, scripted with technical assistance from the New Delhi-based Biotech Consortium India Limited, speaks of bringing home the most advantageous "biotechnology research and development' to solve almost all the problems of this poorest …
The EU's efforts to increase the use of genetically modified (GM) food products in member nations have suffered a big blow. The European Commission (EC), EU's administrative wing, had proposed to order five member countries to lift their bans on certain GM products. But environment ministers of 22 of the …
The Biotechnology Strategy document (dbt, 2005) reinforces our conviction that policy and practice in this area of science and technology (s&t;) has to go beyond conventional research for technology generation. Proclaimed as
the Union government has announced its action plan for the biotechnology sector but it reads more like a wish list prepared by an industry pressure group. The draft National Biotechnology Development Strategy seeks to propel the current us$750 million biotech industry to a us $5-billion one, employing about one million …
Main features of the draft: • Envisages a US $5 billion Indian biotech industry that offers 1 million jobs by 2010 • About 30 per cent of Rs 200 crore DBT research funds for public-private partnership research • Better curricula and accreditation for biotech education • Single regulator for all …
Controversy and genetically modified (gm) foods are inseparable. Science journal Nature reported on March 23, 2005 that biotech firm Syngenta International ag had inadvertently distributed an unauthorised variety of gm corn (b t10) in the us between 2001 and 2004. Syngenta says it informed us authorities of the matter as …
Watch out Monsanto et al. A small non-profit biotech research organisation in Australia is out to change the industry. cambia has found a new way of transferring genetic material to plants; it bypasses the heavily-patented agrobacterium transformation (at) method. Moreover, cambia researchers have placed this tool in the public sphere …
Angola recently banned the import of all genetically modified organisms (gmo s ), except those meant for food aid for its people. un food aid feeds nearly one million Angolans. The decision to impose the ban was taken by the country's council of ministers, state run news agency Angop said. …
two genes of a malaria parasite that are responsible for its multiplication have been silenced by scientists at the International Centre for Genetic Engineering and Biotechnology (icgeb), New Delhi. The scientists say their work, carried out on mice, may provide a new approach to treat the disease in humans. A …
In 1982, the us-based multinational El-Lily produced and commercialised the first therapeutic recombinant protein, humulin (human insulin). That was the first instance of a pharmaceutical firm venturing into biotechnology. By the late 1980s, all the 20-odd us pharmaceutical majors were into biotechnology. Companies in uk and in many other parts …
Is transgenic technology the only option to solve problems faced by agriculture today? Yields from major cereals have virtually saturated. And the global population is expected to increase by 50 per cent by 2050. Now, how do you feed 9 billion mouths? Organic agriculture can at best feed 4 billion …
Pharmaceutical giant Ranbaxy Laboratories Ltd's Rs 107 crore expansion plan in Himachal Pradesh's Sirmour district has become a bitter pill the company's being made to swallow. Farmers' suspicions, indeed outright distrust, have placed the company's initiative to expand the capacity of an existing plant at Ganguwala, Paonta Sahib, under a …
function illus() { var popurl="image/20040831/42.jpg" winpops=window.open(popurl,"","width=600,height=370,scrollbars=yes") } How would you find the prospect of little machines crawling inside your innards to cure some terrible disease? Intrigued? Repulsed? Welcome to the happening world of nanotechnology, where scientists work on atoms and molecules to fashion intrusive devices like the one described above. …
a communication gap between the Genetic Engineering Approval Committee (geac) and Department of Biotechnology (dbt) recently triggered a controversy involving an indigenous drug for acute myocardial infarction (heart attack). The geac ticked off Hyderabad-based Shanta Biotechnics Private Limited, the developer of the drug, for undertaking the clinical trials of the …
pro-farmer groups have questioned the credibility of a study stating that the acreage under transgenic crops is increasing at a much faster rate in developing countries than the industrialised nations. As per the groups, the study drew such conclusions as it has been conducted by the us-based International Services for …
